HUBUNGAN KONTRASEPSI HORMONAL DENGAN KANKER SERVIKS DI RSUP DR. MOHAMMAD HOESIN PALEMBANG

ARDIYANI, NOVETANIA VIRA and Manan, Heriyadi and Nurtjahyo, Awan (2021) HUBUNGAN KONTRASEPSI HORMONAL DENGAN KANKER SERVIKS DI RSUP DR. MOHAMMAD HOESIN PALEMBANG. Undergraduate thesis, Sriwijaya University.

[thumbnail of RAMA_11201_04011281823150.pdf] Text
RAMA_11201_04011281823150.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (3MB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_01_front_ref.pdf]
Preview
Text
RAMA_11201_04011281823150_8817230017_0031037508_01_front_ref.pdf - Accepted Version
Available under License Creative Commons Public Domain Dedication.

Download (612kB) | Preview
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_02.pdf] Text
RAMA_11201_04011281823150_8817230017_0031037508_02.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (585kB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_03.pdf] Text
RAMA_11201_04011281823150_8817230017_0031037508_03.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (215kB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_04.pdf] Text
RAMA_11201_04011281823150_8817230017_0031037508_04.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (232kB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_05.pdf] Text
RAMA_11201_04011281823150_8817230017_0031037508_05.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (116kB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_06_ref.pdf] Text
RAMA_11201_04011281823150_8817230017_0031037508_06_ref.pdf - Bibliography
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (134kB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_8817230017_0031037508_07_lamp.pdf] Text
RAMA_11201_04011281823150_8817230017_0031037508_07_lamp.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (2MB) | Request a copy
[thumbnail of RAMA_11201_04011281823150_TURNITIN.pdf] Text
RAMA_11201_04011281823150_TURNITIN.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (6MB) | Request a copy

Abstract

Cervical cancer is the second most common cancer new case and the third most cancer death case in 2020. New cases and cervical cancer deaths are expected to increase in 2040. The main risk factor for cervical cancer is HPV infection. Hormonal contraception is one of the risk factors for cervical cancer. Hormonal contraceptives are still in demand by active contraceptive acceptors in Palembang. Other risk factors for cervical cancer are parity > 3 children, low education, not working, smoking, marriage history > 1 time, family history of cervical cancer, age at first marriage <20 years. This study aims to determine the relationship between the use of hormonal contraception and cervical cancer. An analytical observational study with astudy approach case-control with patient interviews of 21 cervical cancer patients and 21 non-cervical cancer patients, namely pregnant women and mothers after giving birth aged 20 years at the Inpatient and Polyclinic Department of Obstetrics and Gynecology Dr. Mohammad Hoesin Palembang from October to November 2021. Data collection used a consecutive sampling technique. Data were analyzed using univariate analysis and bivariate analysis (Chi-square). The results of this study are use of hormonal contraception (p=0.005; OR=6.9), duration of use of hormonal contraception >5 years (p=0.001; OR=13), type of injectable hormonal contraception (p=0.035; OR=5.2) and implants (p=0.000; OR=4.25) was significantly associated with cervical cancer. Meanwhile, duration of use of hormonal contraception ≤5 years, type of hormonal contraceptive pill, parity, education, occupation, smoking, marital history, family history, and age at first marriage were not significantly associated with cervical cancer (p>0.005). The use of hormonal contraception is the most dominant variable affecting cervical cancer. The use of hormonal contraceptives is significantly associated with cervical cancer. Keywords: Cervical cancer, hormonal contraception, risk factors

Item Type: Thesis (Undergraduate)
Uncontrolled Keywords: Kanker serviks, kontrasepsi hormonal, faktor risiko
Subjects: R Medicine > R Medicine (General) > R5-920 Medicine (General)
Divisions: 04-Faculty of Medicine > 11201-Medicine (S1)
Depositing User: Novetania Vira Ardiyani
Date Deposited: 05 Jan 2022 04:37
Last Modified: 05 Jan 2022 04:37
URI: http://repository.unsri.ac.id/id/eprint/60716

Actions (login required)

View Item View Item